Home > PIE > Search result

    Total: 596

    Relato de Diálogo Deliberativo Evidências para Políticas de Saúde: Reduzindo as taxas de cirurgia cesariana no Brasil

    Setti, Cecília; Oliveira, Cintia de Freitas; Toma, Tereza Setsuko.
    Diálogo deliberativo ou diálogo de políticas é um recurso utilizado para propiciar o compartilhamento de saberes entre pesquisadores, formuladores de política e demais interessados sobre uma temática a ser discutida. Ainda, tem como objetivo revisar o conteúdo da síntese de evidências, articular...
    Policy Making, Cesarean Section/statistics & numerical data, Brazil
    Fulltext

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 13 September 2021

    Pan American Health Organization.
    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...
    SARS-CoV-2/drug effects, COVID-19/drug therapy, Immunologic Factors/therapeutic use, Antiviral Agents/therapeutic use, Clinical Trials as Topic
    Fulltext (primary link)     Fulltext (alternative link)    

    Relato de Diálogo Deliberativo Evidências para Políticas de Saúde: Reduzindo as taxas de cirurgia cesariana no Brasil

    Setti, Cecília; Oliveira, Cintia de Freitas; Toma, Tereza Setsuko Toma.
    Diálogo deliberativo ou diálogo de políticas é um recurso utilizado para propiciar o compartilhamento de saberes entre pesquisadores, formuladores de política e demais interessados sobre uma temática a ser discutida. Ainda, tem como objetivo revisar o conteúdo da síntese de evidências, articular...
    Policy Making, Cesarean Section/statistics & numerical data, Brazil
    Fulltext

    Síntese de evidências para políticas de saúde: reduzindo as taxas de cirurgia cesariana no Brasil

    Setti, Cecília; Oliveira, Cintia de Freitas; Tesser, Taís Rodrigues; Bortoli, Maritsa Carla de; Araújo, Bruna Carolina; Melo, Roberta Crevelario; Olah, Andressa Rocha; Venâncio, Sônia Isoyama; Poderoso, Rosana Evangelista; Toma, Tereza Setsuko.
    O problema: O Brasil é o segundo país com as taxas mais elevadas de cirurgia cesariana no mundo, muito além da recomendação de 10 a 15% da Organização Mundial da Saúde (WHO et al., 2015). O uso excessivo e desnecessário de tecnologias na atenção ao parto e nascimento tem contribuído para aume...
    Cesarean Section/statistics & numerical data, Labor, Obstetric, Doulas, Prenatal Care, Vaginal Birth after Cesarean, Policy Making, Health Policy
    Fulltext

    Ongoing living update of potential COVID-19 therapeutics options: summary of evidence - 20 April 2021

    Pan American Health Organization.
    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...
    SARS-CoV-2/drug effects, COVID-19/drug therapy, Immunologic Factors/therapeutic use, Antiviral Agents/therapeutic use, Clinical Trials as Topic
    Fulltext (primary link)     Fulltext (alternative link)    

    Ongoing living update of potential COVID-19 therapeutics options: summary of evidence - 5 August 2021

    Pan American Health Organization.
    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...
    SARS-CoV-2/drug effects, COVID-19/drug therapy, Immunologic Factors/therapeutic use, Antiviral Agents/therapeutic use, Clinical Trials as Topic
    Fulltext (primary link)     Fulltext (alternative link)    

    Ongoing living update of potential COVID-19 therapeutics options: summary of evidence - 22 June 2021

    Pan American Health Organization.
    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...
    SARS-CoV-2/drug effects, COVID-19/drug therapy, Immunologic Factors/therapeutic use, Antiviral Agents/therapeutic use, Clinical Trials as Topic
    Fulltext (primary link)     Fulltext (alternative link)    

    Ongoing living update of potential COVID-19 therapeutics options: summary of evidence - 14 July 2021

    Pan American Health Organization.
    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...
    SARS-CoV-2/drug effects, COVID-19/drug therapy, Immunologic Factors/therapeutic use, Antiviral Agents/therapeutic use, Clinical Trials as Topic
    Fulltext (primary link)     Fulltext (alternative link)